Beginning Jan. 1, 2026, Optum Rx, the pharmacy benefit manager of UnitedHealthcare, will reduce reauthorizations for an ...
Optum Rx remove reauthorization requirements for 40 drugs starting Jan. 1 to streamline access and expand automated prior authorization.
Optum Rx will reduce reauthorizations on 40 additional medications Jan. 1, surpassing initial goals set out earlier this year. | Optum Rx will reduce reauthorizations on 40 additional medications on ...
Three drugs treating chronic conditions are set for Food and Drug Administration review by the end of the year, and a new report from Optum Rx digs into why payers should be watching these decisions.
In its inaugural Drug Pipeline Insights Report, OptumRx highlights five drugs expected to make waves soon in the healthcare industry for clinical quality, effectiveness and cost. They are listed below ...
OptumRx has published its quarterly Drug Pipeline Insights Report, which highlights three notable drugs that could have a significant impact on payers and patients. The drugs are currently being ...
Optum Rx is committed to making prescription drugs more affordable and the pharmacy experience simpler for consumers with chronic conditions, eliminating up to 25% of reauthorizations, which is equal ...
CVS Caremark Rx blasted the findings for cherry picking certain drugs in an effort to push what it called an 'anti-PBM' ...
Oklahoma AG Drummond issued a cease and desist to OptumRx over alleged illegal clawbacks and deceptive practices.
The State Attorney General has issued a cease-and-desist letter to OptumRx concerning reports that the pharmacy benefit manager attempted to engage in illegal, retroactive reimbursement clawbacks ...
AG Gentner Drummond ordered OptumRx to stop illegal reimbursement clawbacks after the PBM tried to retroactively recoup pharmacy payments.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback